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Sputum culture for the diagnosis of tuberculous pleural effusion: 
analysis of absolute and incremental yields
Abstract
Introduction: Pleural	fluid	culture	yield	in	tuberculous	pleural	effusion	(TPE)	is	disappointing	in	immunocompetent	hosts.	Herein,	
we	attempt	to	define	the	role	of	serial	sputum	cultures	in	the	diagnosis	of	TPE.
Material and methods: We	identified	cases	diagnosed	with	TPE	over	a 16-year	period	in	a high-prevalence	US	hospital.	Absolute	
yields	of	one,	two,	and	three	sputa	were	calculated	as	well	as	the	incremental	yield	of	adding	second	and	third	sputa.	These	
calculations	were	then	performed	separately	for	expectorated	and	induced	sputum	and	for	patients	with	and	without	infiltrates	
on	chest	X-ray. 
Results: Sixty	sputum	collections	were	performed	in	46	patients	with	TPE.	The	per-patient	sensitivity	of	sputum	culture	was	
45.6%.	On	a per-sputum	collection	basis,	the	overall	yield	of	the	first	sputum	was	30%,	of	two	sputa	39%,	and	of	three	sputa	
54%.	The	corresponding	incremental	yields	were	9%	and	15%,	respectively.	The	three-sputum	yields	of	expectorated	and	induced	
collections	were	similar.	The	three-sputum	yield	in	patients	with	infiltrates	on	X-ray	was	11%	lower	than	that	in	those	without	
infiltrates.	
Conclusions: Serial	sputum	collection	of	three	specimens	can	be	expected	to	produce	a yield	of	>	50%	in	cases	of	suspected	
TPE	regardless	of	whether	obtained	by	expectoration	or	induction,	and	the	yield	increases	incrementally.	
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Introduction
Although its incidence is slowly declining 
worldwide, tuberculosis (TB) remains a prevalent 
and morbid infection affecting predominantly 
the developing world [1]. The United States has 
experienced a sharp decline in TB incidence over 
the last two decades after an increase during the 
early years of the acquired immunodeficiency 
syndrome (AIDS) epidemic. Despite this trend, 
US urban centers such as New York City (NYC) 
continue to experience a heavy disease burden 
owing to their large immigrant populations from 
regions endemic for TB. Within NYC, the borough 
of Queens — in which the study institution is lo-
cated — consistently reports the highest incidence 
of TB cases [2]. 
Tuberculous pleural effusion (TPE) is among 
the commonest manifestations of extrapulmonary 
TB and therefore an important clinical entity in 
areas of high TB prevalence. Although a lympho-
cyte-predominant exudative effusion with a high 
adenosine deaminase (ADA) level can be virtually 
diagnostic of TPE in such settings, microbiologi-
cal confirmation may be desirable in uncertain 
cases and allows determination of antibiotic 
sensitivity. By itself, pleural fluid culture for 
acid-fast bacilli (AFB) has been associated with 
yields well below 30% in multiple studies among 
human immunodeficiency virus (HIV) negative 
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cases [3]. Yields above 80% can be achieved by 
means of pleural biopsy specimens submitted for 
AFB culture and histological analysis, but this 
constitutes an invasive procedure with variable 
availability across centers. Sputum testing for 
AFB smear and culture has traditionally been 
considered a low-yield approach to the diagnosis 
of TPE, especially in HIV negative patients and 
those without overt parenchymal involvement on 
chest radiography (CR) [3]. Theoretically, sputum 
collection — by induction or expectoration — 
would be a highly efficient way of diagnosing 
TPE because of its low cost, broad availability, 
and well-established role in the diagnosis of 
pulmonary TB, for which a series of three sequ-
ential specimens is recommended as a means of 
potentially increasing sensitivity [4]. 
Only one contemporary study performed in 
Brazil was conducted specifically to address the 
utility of (induced) sputum collection in patients 
with suspected TPE, showing that the diagnosis 
can be made in this fashion in over 50% of cases, 
which held true even in the absence of paren-
chymal disease on CR [5]. The aim of the present 
study was to determine whether these findings 
can be replicated in a high-prevalence US hospital 
while also determining whether the collection of 
a second and third serial sputum sample in TPE 
results in a progressively increasing yield.
Material and methods
Case identification
The study was approved by the institutional 
review board of the Icahn School of Medicine 
at Mount Sinai [#15-2321(0001)]. Records of all 
patients evaluated at Elmhurst Hospital Center — 
a 545-bed municipal community teaching ho-
spital — during the period of 01/01/1999 to 
02/28/2015 and coded for both tuberculosis [Inter-
national Classification of Diseases (ICD)-9 011.9] 
and pleural effusion (ICD-9 511.9). The 158 cases 
thus identified were then screened for the presen-
ce of TPE, which was diagnosed if one or both of 
the following two sets of criteria was met:
a)  Pathological/mycobacteriological criteria 
(one required):
 — Granulomas on pleural biopsy with or 
without mycobacterial tissue smear/cul-
ture positivity;
 — Pleural fluid or tissue mycobacterial sme-
ar/culture positive for M. tuberculosis;
b)  Clinical criteria (all required):
 — Exudative, lymphocyte-predominant 
pleural effusion;
 — Pleural fluid cytology negative for mali-
gnancy;
 — Pleural fluid ADA level >40 U/L.
An additional inclusion criterion was at least 
one sputum sample submitted for mycobacterial 
smear and culture by either the expectorated or 
induced route at the time of the index hospitali-
zation or within the subsequent 30 days. 
Mycobacteriological processing
Each patient could have undergone expec-
torated sputum collection, induced sputum 
collection, or both. In the study institution, 
sputum induction is performed using isotonic 
or hypertonic saline (NaCl) in accordance with 
recommended procedure [6]. Sputum for AFB is 
typically collected once per day on consecutive 
days. To evaluate a  smear, sputum specimens 
submitted for AFB testing are concentrated by 
centrifugation, and 1–2 drops of the resulting 
pellet are used to prepare a slide, which is then 
air dried and heat fixed. The dried material un-
dergoes fluorochrome (Auramine-O) staining 
and is examined using fluorescence microscopy. 
Smears deemed to contain fluorescent bacilli are 
subjected to confirmatory Kinyoun staining at 
room temperature. If the Kinyoun stain is likewise 
positive, a sample is sent for ribosomal ribonuc-
leic acid (rRNA) amplification testing using the 
Amplified Mycobacterium tuberculosis Direct 
Test™ (Hologic, Inc., San Diego, CA, USA). For 
AFB culture, fluid preparations are incubated in 
the BD BACTEC™ MGIT™ automated mycobacte-
rial detection system (Beckton, Dickinson & Co., 
Franklin Lakes, NJ, USA). Solid preparations for 
AFB culture are plated onto Löwenstein-Jensen 
medium. All cultures are monitored for at least 
6 weeks. If positive, they are monitored for 10 
weeks and sent for AccuProbe™ Mycobacterium 
Tuberculosis Complex Culture Identification Test 
(Hologic, Inc., San Diego, CA, USA).
Yield calculations
The unit of analysis was each sputum col-
lection of up to three samples. The primary 
measurements of interest were the one-sputum, 
two-sputum, and three-sputum culture yields 
for M. tuberculosis along with the respective 
incremental yield of adding the second sputum 
to the first and then the third sputum to the first 
and second. These yields were calculated for all 
sputum collections irrespective of method as 
well as separately for expectorated and induced 
collections. Additionally, overall, expectorated, 
and induced yields were calculated separately 
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for those collections performed in patients with 
and without parenchymal abnormalities (e.g., con-
solidations, nodules, masses, reticular opacities) on 
the CR — regardless of the number of projections 
— that initially demonstrated the pleural effusion. 
The presence or absence of parenchymal chest 
radiograph abnormalities (and effusion size) was 
determined based on the official report by the ra-
diologist as well as image review — when available 
— by several of the study authors experienced in 
chest radiography interpretation (SK, AG, VK, and 
OE). Chest computed tomography (CT) was not 
routinely performed in these patients and therefore 
was not used for adjudication. For the purposes of 
sputum culture yield determination of up to three 
samples, including the incremental yield, the follo-
wing notation was used to designate each collection 
as originally proposed by Rieder et al. [7]:
— Pxx = first sputum positive, second and third 
sputa of no interest;
— NPx = first sputum negative, second sputum 
positive, third sputum of no interest;
— NNP = first and second sputa negative, third 
sputum positive;
— N99 = first sputum negative, second and 
third sputa not obtained;
— NN9 = first and second sputa negative, third 
sputum not obtained;
— NNN = all three sputa negative.
Using this notation, the yield of obtaining one 
sputum was calculated as follows:
a) One sputum yield = Pxx/total number of 
sputum collections
The yield of obtaining two sputa was defined 
as collections positive on first sputum plus col-
lections positive on second sputum divided by 
all collections minus those that did not contain 
a second sputum despite a negative first sputum:
b) (Pxx + NPx) / (total number of sputum 
collections — N99)
Correspondingly, the yield when three sputa 
are obtained was defined as collections positive 
on first sputum plus collections positive on se-
cond sputum plus collections positive on third 
sputum divided by all collections minus those 
that did not contain a  second sputum despite 
a negative first sputum and minus those that did 
not contain a third sputum despite a negative first 
and second sputum:
c) (Pxx + NPx + NNP) / (total number of 
sputum collections — N99–NN9)
The incremental yield of obtaining two sputa 
as opposed to one was therefore designated as b–a, 
and similarly the incremental yield of obtaining 
three sputa instead of two was designated as c–b.
Statistical Methods
Chi-square or Fisher’s exact test was used to 
examine for significant differences in categorical 
baseline variables between patients with and 
without lung disease on CR. Student’s T-test or 
Wilcoxon rank-sum test was used to investigate 
for significant differences in continuous baseline 
variables between patients with and without lung 
disease on CR.
Results
Of the 158 potential cases of TPE identified, 
46 met the study criteria for TPE. These 46 pa-
tients underwent a total of 60 sputum collections: 
27 expectorated collections and 33 induced col-
lections; 14 patients underwent both. Of the latter 
14 cases, only 3 had non-diagnostic expectorated 
collections but diagnostic induced collections. 
All of the 46 patients had at least one sputum 
specimen collected. Of the 27 expectorated col-
lections, 23 (85%) were complete collections (i.e., 
Pxx, NPx, NNP, and NNN); of the 33 induced 
collections, 27 (82%) were complete All but two 
patients had sputum collected during the index 
hospital admission; the two who did not under-
went collection within one month following their 
admission, and both had positive AFB culture 
results (Pxx). 
The characteristics of the 46 patients with 
TPE eligible for analysis are summarized in Ta-
ble 1. All of the patients with a known country 
of origin were born outside the United States, 
predominantly in Hispanic and Asian coun-
tries. The overwhelming majority of those with 
a known status were HIV negative. The majority 
(76%) of effusions were moderate to large. Most 
cases (33/46 or 72%) fulfilled the pathological/ 
/mycobacteriological criteria for diagnosis of TPE 
as outlined above. The remaining 28% met only 
the clinical criteria. No patient had a positive 
pleural fluid AFB smear, but of the 45 patients 
whose pleural fluid underwent mycobacterio-
logical analysis, 16 (35%) had a positive AFB 
culture. 
On a per-patient basis (N = 46), the sen-
sitivity of sputum culture was 45.6%. On a per
-sputum collection basis (N = 60), the overall 
sensitivity was 45.0%. The yields of one, two, 
and three sputa for the diagnosis of TPE ir-
respective of collection method were 30.0%, 
38.9%, and 54.0%, respectively. The incremental 
yield of adding the second sputum to the first 
was 8.9%, and the incremental yield of adding 
the third sputum to the initial two was 15.1%. 
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Table 1. Characteristics of the study patients
Variable CXR with lung  
disease (n = 29)
CXR without lung 
disease (n = 17)
All patients  
(n = 46)
P-value
Age mean ± SD 35.7	±	20.0 34.8	±	12.8 35.4	±	17.5 0.8602*
Gender (%)
Male	 17	(59) 12	(71) 29	(63) 0.4170
Female 12	(41) 5	(29) 17	(37)
Ethnicity (%)a
Hispanic 13	(45) 10	(59) 23	(50) 0.5144**
Asian	 13	(45) 4	(34) 17	(37)
African	 2	(7.0) 2	(12) 4	(9.0)
Unknown	 1	(3.0) 1	(6.0) 2	(4.0)
HIV status (%)a
Positive 1	(3.0) 2	(12) 3	(7.0) 0.1518**
Negative 23	(79) 9	(53) 32	(70)
Unknown 5	(17) 6	(35) 11	(24)
PPD/IGRA status (%)a
Positive	 11	(38) 5	(29) 16	(35) 0.6557**
Negative 3	(10) 1	(6.0) 4	(9.0)
Unknown/indeterminate 15	(52) 11	(65) 26	(57)
Effusion size (%)a
Small 6	(21) 1	(6.0) 7	(15) 0.2441**
Moderate 11	(38) 5	(29) 16	(35)
Large 11	(38) 8	(47) 19	(41)
Unknown	 1	(3.0) 3	(18) 4	(9.0)
Pleural fluid chemistry median (IQR)
LDH	(U/L) 518	(262–683) 646	(399–766) 535	(325–704) 0.1302***
Lymphocyte	fraction 73	(65–92) 80	(69–93) 80	(65–92) 0.5765***
Adenosine	deaminase	(U/L) 49.5	(32.9–60.2)b 52.5	(43.9–58.1)c 52.0	(38.3–60.3)d 0.4948***
Pleural fluid mycobacteriology (%)
AFB	smear	positive 0	(0) 0	(0) 0	(0) 0.3696**
AFB	smear	negative 29	(100) 16	(94) 45	(98)
AFB	smear	unavailable 0	(0) 1	(6.0) 1	(2.0)
Pleural fluid mycobacteriology (%)
AFB	culture	positive 10	(34) 6	(35) 16	(35) 0.5811**
AFB	culture	negative 19	(66) 10	(59) 29	(63)
AFB	culture	unavailable 0	(0) 1	(6.0) 1	(2.0)
Pleural tissue (%)
Granulomas	present 17	(59) 13	(76) 30	(65) 0.5257**
Granulomas	absent 4	(14) 1	(6.0) 5	(11)
Not	biopsied 8	(28) 3	(18) 11	(24)
Pleural tissue (%)
AFB	culture	positive 3	(10) 2	(12) 5	(11) 0.8970**
AFB	culture	negative/unavailable 18	(62) 12	(71) 30	(65)
Not	biopsied 8	(28) 3	(18) 11	(24)
Æ
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Table 1 cont. Characteristics of the study patients
Variable CXR with lung  
disease (n = 29)
CXR without lung 
disease (n = 17)
All patients  
(n = 46)
P-value
Biopsy type (%)
Needle 20	(69) 12	(71) 32	(70) 0.5332**
Surgical 1	(3.0) 2	(12) 3	(7.0)
Not	done 8	(28) 3	(18) 11	(24)
Basis for TPE diagnosis (%)
Histology/mycobacteriology 19	(66) 14	(82) 33	(72) 0.3150**
Pleural	fluid	clinical	criteria	only 10	(34) 3	(18) 13	(28)
Sputum for AFBe (%)
Expectorated	(E)	collection 14	(48) 13	(76) 27	(59) N/A
Induced	(I)	collection 23	(79) 10	(59) 33	(72)
At	least	1	complete	collection	(E	or	I) 27	(93) 16	(94) 43	(93)
aPercentages	may	not	add	up	to	100%	due	to	rounding;	bBased	on	data	from	14	patients;	cBased	on	data	from	8	patients;	dBased	on	data	from	22	patients;	eTotals	add	
up	to	more	than	the	number	of	patients	because	some	patients	had	both	types	of	collections;	*By	T-test;	**By	Fisher’s	Exact	Test,	otherwise	by	Chi-Square	Test;	***By	
Wilcoxon	rank-sum	Test.
IGRA	—	interferon	gamma	release	assay;	LDH	—	lactate	dehydrogenase;	N/A —	not	applicable;	PPD	—	purified	protein	derivative;	IQR	—	interquartile	range
The three-sputum yields of expectorated and 
induced collections were similar: 52.2% versus 
55.6%, respectively. Table 2 summarizes these 
results and separately displays the correspon-
ding absolute and incremental yields of expec-
torated and induced collections.
When analyzed according to the presence or 
absence of parenchymal abnormalities on CR, the 
three-sputum yield was higher in the latter group: 
46.9% versus 57.9%, a difference of 11%. Table 3 
presents the full absolute and incremental yield 
breakdown based on separation by this parameter 
as well as after further subdivision by sputum 
collection method.
Of the 27 diagnostic sputum collections, 
two-thirds (18) were positive on the first sputum, 
and the remaining one-third became positive 
only on the second or third sputum. The second 
sputum was the first diagnostic specimen in 3/27 
collections (11.1%), whereas the third sputum 
was the first diagnostic specimen in 6/27 collec-
tions (22.2%). 
Discussion
This retrospective analysis of 60 sputum 
collections in 46 patients with TPE is one of the 
few studies on the diagnosis of this condition 
ever conducted in the United States, a non-ende-
mic country for TB. Given the persistently high 
incidence of TB in the part of NYC in which the 
study institution is located, it is not surprising 
that one of the earliest US series of TPE patients 
was published in 1973 by the same institution [8]. 
Our results are in agreement with prior reports 
indicating that the yield of sputum culture for 
the diagnosis of TPE can exceed 50%, making 
it likely the second most sensitive diagnostic 
modality for TPE after pleural biopsy, which 
is much more uncomfortable and invasive. Im-
portantly, our study is the first to examine the 
question of whether serial sputum collection of 
up to three distinct specimens for mycobacterial 
culture results in progressive increase in diagno-
stic yield in cases of TPE like it does in cases of 
parenchymal TB. Analysis of our entire sample 
shows that, in fact, three sputum specimens may 
be required to achieve a greater than 50% yield 
for TPE, a finding that is mirrored by a separate 
analysis of expectorated and induced collections. 
An 8.9% incremental yield was observed with 
the addition of sputum #2 and a further 15.1% 
increase was seen with the addition of sputum 
#3, for an overall incremental yield of obtaining 
three sputa as opposed to one of 24.0%. One-third 
of the diagnostic sputum collections in our study 
would have been non-diagnostic had they been 
limited to only a single sputum. One quarter of 
the diagnoses would have been missed without 
the third sputum. 
It would be reasonable to speculate that 
sputum cultures obtained from TPE patients with 
concurrent parenchymal abnormalities on CR 
will have higher diagnostic yield. The opposite 
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Table 4. Comparison of sputum AFB culture yields among five contemporary studies
Parameter Seibert 1991 [7] Valdés 1998 [8] Conde 2003 [5] Ruan 2012 [9] Present study*
Country USA	(AL) Spain Brazil Taiwan USA	(NY)
Design Retrospective Retrospective Prospective Retrospective Retrospective
Number	of	patients 70 254 84 382 46
Collection	method Unspecified Unspecified Induction Unspecified Induction	
Sputum	AFB	smear	yield Not	reported 62.5% 11.9% Not	reported 0%
Sputum	AFB	culture	yield 50.0% 100% 52.4% 48.2% 55.6%
*Listed	culture	yield	is	based	on	collection	of	three	sputa	by	induction.
AFB	—	acid-fast	bacilli
Table 3.  Sputum yields of patients with and without parenchymal disease on CXR, including further subdivision by collec-
tion method
Number of sputa Overall yield Incremental yield Expectorated yield Incremental 
yield
Induced yield Incremental 
yield
CXR with lung 
disease
One 10/37	(27.0%) N/A 4/14	(28.6%) N/A 7/23			(30.4%) N/A
Two 13/35	(37.1%) +10.1% 4/14	(28.6%) 0% 10/21	(47.6%) +17.2%
Three 15/32	(46.9%) +9.8% 5/13	(38.5%) +9.9% 11/19	(57.9%) +10.3%
CXR without 
lung disease
One 7/23			(30.4%) N/A 4/13	(30.8%) N/A 3/10			(33.3%) N/A
Two 7/20			(35.0%) +4.6% 4/11	(36.4%) +5.6% 3/8					(37.5%) +4.2%
Three 11/19	(57.9%) +22.9% 7/10	(70.0%) +33.6% 4/8					(50.0%) +12.5%
N/A —	not	applicable
Table 2.  Overall and separate expectorated and induced yields of one, two, and three sputa
Number of 
sputa
Overall yield Incremental yield Expectorated yield Incremental 
yield
Induced yield Incremental 
yield
One 18/60	(30.0%) N/A 8/27	(29.6%) N/A 10/33	(30.3%) N/A
Two 21/54	(38.9%) +8.9% 8/25	(32.0%) +2.4% 13/29	(44.8%) +14.5%
Three 27/50	(54.0%) +15.1% 12/23	(52.2%) +20.2% 15/27	(55.6%) +10.8%
N/A —	not	applicable
was true, however, in the study by Conde et al.: 
45.0% with parenchymal lesions versus 54.7% 
without. When we separated all of our sputum 
collections by whether the corresponding patient 
did or did not have parenchymal CR abnorma-
lities, as in the Conde study, the three-sputum 
yield was numerically higher in the group with 
no parenchymal lesions than in the group with 
such lesions: 57.9% versus 46.9%, respectively. 
It should be borne in mind that these numbers, 
which are very similar between the two stu-
dies, were achieved in the present study only 
with the collection of three sputum samples. 
For comparison, single-sputum yields with and 
without parenchymal disease were 27.0% and 
30.4%, respectively, while the corresponding 
two-sputum yields were 37.1% and 35.1%. For 
clinical purposes, the patient type of greater in-
terest is the one with suspected TPE but without 
parenchymal CR abnormalities in whom sputum 
collection may not be automatically triggered by 
concern for pulmonary TB. TPE is believed to 
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result from a pleural hypersensitivity reaction 
to a sub-pleural focus of pulmonary TB, which 
explains the disappointing mycobacterial yield of 
pleural fluid culture in immunocompetent hosts, 
so it is not surprising that sputum culture would 
have substantial yield in this condition. Why TPE 
patients without visible parenchymal infiltrates 
on CR might have even higher sputum yield than 
those with radiographic parenchymal disease — 
as in the current study and the one by Conde et 
al. — remains unexplained. Effusion size, which 
could affect the ability to discern lung involve-
ment on CR, was equally distributed by category 
between those with and without parenchymal 
disease in our sample (Table 1). It is possible that 
the ability to review chest CT images would have 
increased the detection rate of lung abnormalities 
as has been shown previously [9]. Of note, none 
of the sputum samples included in our study was 
positive for AFB on examination of the smear.
In the last 30 years, our study is among four 
others to report on the yield of sputum culture 
in TPE: Seibert et al. [10] in 1991 (a US registry 
review from Alabama), Valdés et al. [11] in 1998 
(Spain), the aforementioned Conde study from 
Brazil in 2003, and a Taiwanese study by Ruan 
et al. [12] in 2012. Seibert et al. included 70 TPE 
patients in their analysis and reported an overall 
sputum yield of 50% without providing any de-
tails about sputum collection method or number 
of specimens per collection. The sputum yield 
was markedly higher in those with an infiltrate 
on CR (88.6%) than in those without (11.4%). It 
is noteworthy that in 67.7% of patients with an 
infiltrate, sputum was the sole diagnostic spe-
cimen. Valdés et al. reviewed 254 patients with 
TPE, of which the 48 with parenchymal disease 
on imaging underwent sputum collection. The 
smear was positive in 62.5% and culture in 100% 
of such cases. As in the Seibert study, no details 
are available about sputum collection methodolo-
gy or quantity. The Conde study, results of which 
have been quoted earlier, was unique in that its 
84 subjects with TPE were evaluated prospecti-
vely. All sputum was collected by induction, but 
the number of sputum samples submitted per 
patient is not specified. This study is the only 
one of the three to provide data on the HIV status 
of its subjects. Similar to our study, the popula-
tion was predominantly HIV negative: 84.5%. In 
patients with abnormal parenchyma, our overall 
three-sputum culture yield (46.9%) as well as the 
yield of induced sputum only (57.9%) are much 
more closely aligned with that in the Conde study 
(54.7%) than with that of Seibert et al. (88.6%) 
and Valdés et al. (100%). Table 4 compares the 
sputum results obtained in these four studies to 
those of the present study. The retrospective Ruan 
study is the largest of the group with 382 cases 
of TPE who also underwent sputum AFB cultu-
re testing, the yield of which was 48% by itself 
and 79% in combination with pleural fluid AFB 
culture. Again, information about the number of 
sputum samples collected and the collection me-
thod is not provided. Notably, in our study, of the 
19 patients with negative sputum who had pleural 
fluid analyzed for AFB, 12 had positive pleural 
fluid for a combined sensitivity of sputum and 
pleural fluid of 71.7%. Our per-patient diagnostic 
yields of sputum alone (45.6%) and of sputum 
plus pleural fluid (71.7%) are in close alignment 
with Ruan et al., which is the largest study of TPE 
diagnostics. According to these numbers, sputum 
and pleural fluid together can approach the yield 
of pleural biopsy. 
Our study has several important limitations 
aside from its retrospective design and reliance 
on the accuracy of ICD coding. Not all of the 
sputum collections were complete sets of three 
specimens, so one-sputum, two-sputum, and 
three-sputum yield calculations were based 
on different numbers of samples. In two cases, 
sputum collection was not performed during the 
index hospitalization. CR interpretation for the 
presence or absence of parenchymal infiltrates 
was based on the impression of a group of study 
authors along with the official radiologist inter-
pretation as opposed to a group of independent 
observers. Many of the subjects in our study were 
diagnosed with TPE presumptively based not on 
pleural histology or mycobacteriology but on the 
combination of suggestive pleural fluid charac-
teristics. For logistical reasons, we were unable 
to corroborate the diagnosis of TPE in these 
presumptive cases by assessing for resolution of 
the pleural effusion following anti-tuberculous 
therapy. Additionally, our already relatively small 
sample size became even smaller once the results 
were separated based on sputum collection me-
thod and then further parsed according to the 
presence or absence of parenchymal involvement.
Summary
In conclusion, despite its relatively small 
sample size, our study corroborates prior pu-
blished literature reporting sputum culture yield 
of approximately 50% in cases of TPE, which 
would place this approach behind only pleural 
biopsy and ahead of pleural fluid culture in the 
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typical hierarchy of diagnostic yields for TPE. 
For unclear reasons, our study is one of two to 
report a  higher sputum culture yield in TPE 
cases not accompanied by lung parenchymal 
findings. Our data also suggest that in clinical 
practice, a yield of > 50% may be reached only 
upon collection of three serial sputum samples 
akin to the common practice in pulmonary TB. 
The difference in yield between obtaining one 
sputum versus three sputa could be in the range 
of 20–25% according to our data, so in aggregate 
these results support obtaining a  set of three 
sputum samples in all patients presenting with 
a pleural effusion for which pleural TB is an 
etiological consideration.
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